Follow-up results of looking at treatment with ibrutinib on CLL patient survival and adverse events
Are complex karyotypes reliable prognostic markers for CLL?
CLL therapy - current status and issues
Identifying predictive markers for CLL
CLL2-GIVe trial: investigating chemotherapy-free treatment of CLL